The Claim
BPC 157 at concentrations of 0.5–2 μg/ml increases phosphorylation of FAK and paxillin in rat tendon fibroblasts without altering total protein levels, indicating activation of the FAK-paxillin signaling pathway.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
BPC 157 at concentrations of 0.5–2 μg/ml increases phosphorylation of FAK and paxillin proteins in rat tendon fibroblasts without changing their total amount, which indicates activation of the FAK-paxillin signaling pathway.
See the scientific wording
BPC 157 at concentrations of 0.5–2 μg/ml dose-dependently increases phosphorylation of FAK and paxillin in rat tendon fibroblasts without altering total protein levels, indicating activation of the FAK-paxillin signaling pathway as a potential mechanism for enhanced cell migration and spreading.
BPC 157 binds to a receptor on the surface of tendon cells, triggering a chain reaction that turns on FAK and paxillin proteins. These activated proteins reorganize the cell's internal skeleton, allowing the cells to spread out and move faster to repair damaged tendon tissue.
What the research says
1 studyBPC 157 helps rat tendon cells move and spread better by turning on a specific internal signal (FAK-paxillin) without making more of those proteins — just making them more active.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.